Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
SUNG OK
Principal Investigator Last Name
YOON
Awardee Organization
Awardee State
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$837,118
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official